The journey towards equitable clinical trials in healthcare requires confronting and learning from past transgressions. For those leading patient advocacy in the biotech and pharmaceutical sectors, recognizing these historical challenges is vital to fostering trust and diversity in research. Henrietta Lacks’ story, where her cells were used without consent, and the Tuskegee Syphilis Study, which… Continue reading Embracing a New Era in Clinical Trials: Learning from the Past for a More Inclusive Future
Month: February 2024
The Need for Change in the FDA Approval Process: Rebuilding Trust and Ensuring Patient-Centric Approvals
Introduction The Food and Drug Administration (FDA) plays a crucial role in regulating drugs and medical products in the United States. As a central body that approves or disapproves drugs, the FDA holds a significant amount of responsibility for maintaining the safety and efficacy of medical treatments. However, recent controversies surrounding the approval process have… Continue reading The Need for Change in the FDA Approval Process: Rebuilding Trust and Ensuring Patient-Centric Approvals